
Anne Marie Sabrina Wehbe
Examiner (ID: 18312)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1632, 1633, 1634 |
| Total Applications | 1342 |
| Issued Applications | 603 |
| Pending Applications | 239 |
| Abandoned Applications | 542 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8832045
[patent_doc_number] => 20130133090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'TRANSGENIC MAMMALLS MODIFIED IN BRI PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/477397
[patent_app_country] => US
[patent_app_date] => 2012-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12821
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477397
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/477397 | TRANSGENIC MAMMALLS MODIFIED IN BRI PROTEIN EXPRESSION | May 21, 2012 | Abandoned |
Array
(
[id] => 8489065
[patent_doc_number] => 20120288472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN'
[patent_app_type] => utility
[patent_app_number] => 13/476183
[patent_app_country] => US
[patent_app_date] => 2012-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15184
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13476183
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/476183 | REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN | May 20, 2012 | Abandoned |
Array
(
[id] => 8994817
[patent_doc_number] => 08518701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Methods and materials for producing transgenic artiodactyls'
[patent_app_type] => utility
[patent_app_number] => 13/467588
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 11
[patent_no_of_words] => 16961
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467588
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467588 | Methods and materials for producing transgenic artiodactyls | May 8, 2012 | Issued |
Array
(
[id] => 8453166
[patent_doc_number] => 20120264112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY'
[patent_app_type] => utility
[patent_app_number] => 13/456330
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4544
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13456330
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/456330 | METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY | Apr 25, 2012 | Abandoned |
Array
(
[id] => 9517733
[patent_doc_number] => 20140154225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'METHOD FOR COMBINED CONDITIONING AND CHEMOSELECTION IN A SINGLE CYCLE'
[patent_app_type] => utility
[patent_app_number] => 14/112878
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11465
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112878
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112878 | Method for combined conditioning and chemoselection in a single cycle | Apr 19, 2012 | Issued |
Array
(
[id] => 8495936
[patent_doc_number] => 20120295344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Stem Cell Fusion Model of Carcinogenesis'
[patent_app_type] => utility
[patent_app_number] => 13/448251
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12803
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448251
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/448251 | Stem Cell Fusion Model of Carcinogenesis | Apr 15, 2012 | Abandoned |
Array
(
[id] => 8335101
[patent_doc_number] => 20120201808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'Stem Cell Fusion Model of Carcinogenesis'
[patent_app_type] => utility
[patent_app_number] => 13/448112
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6827
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/448112 | Stem cell fusion model of carcinogenesis | Apr 15, 2012 | Issued |
Array
(
[id] => 8699329
[patent_doc_number] => 20130061338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'SCREENING OF DRUG FOR ATTENTION DEFICIT HYPERACTIVE DISORDER BY USING GIT1 KNOCK-OUT MICE AS A NOVEL ADHD MOUSE MODEL'
[patent_app_type] => utility
[patent_app_number] => 13/446789
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5568
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446789
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446789 | Screening of drug for attention deficit hyperactive disorder by using GIT1 knock-out mice as a novel ADHD mouse model | Apr 12, 2012 | Issued |
Array
(
[id] => 9437819
[patent_doc_number] => 20140115726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'NEW TALE-PROTEIN SCAFFOLDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/009509
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 35113
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009509
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/009509 | NEW TALE-PROTEIN SCAFFOLDS AND USES THEREOF | Apr 4, 2012 | Abandoned |
Array
(
[id] => 8315290
[patent_doc_number] => 20120192300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'Common Light Chain Mouse'
[patent_app_type] => utility
[patent_app_number] => 13/412936
[patent_app_country] => US
[patent_app_date] => 2012-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 34453
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/412936 | Common Light Chain Mouse | Mar 5, 2012 | Abandoned |
Array
(
[id] => 8670642
[patent_doc_number] => 20130045180
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2013-02-21
[patent_title] => 'VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/360389
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30629
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360389
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/360389 | VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME | Jan 26, 2012 | Abandoned |
Array
(
[id] => 8670642
[patent_doc_number] => 20130045180
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2013-02-21
[patent_title] => 'VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/360389
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30629
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360389
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/360389 | VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME | Jan 26, 2012 | Abandoned |
Array
(
[id] => 9057193
[patent_doc_number] => 20130254907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'HUMANIZED TRANSGENIC ANIMAL'
[patent_app_type] => utility
[patent_app_number] => 13/989781
[patent_app_country] => US
[patent_app_date] => 2011-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10999
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989781
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989781 | Humanized transgenic animal | Nov 27, 2011 | Issued |
Array
(
[id] => 9175104
[patent_doc_number] => 20130317089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'Compositions and Methods Useful for Treatment and Prevention of Incontinence'
[patent_app_type] => utility
[patent_app_number] => 13/885057
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5795
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885057
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/885057 | Compositions and Methods Useful for Treatment and Prevention of Incontinence | Nov 9, 2011 | Abandoned |
Array
(
[id] => 8196942
[patent_doc_number] => 20120121550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'PRODUCTION OF OLIGODENDROCYTES FROM PLACENTA-DERIVED STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/293037
[patent_app_country] => US
[patent_app_date] => 2011-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20940
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20120121550.pdf
[firstpage_image] =>[orig_patent_app_number] => 13293037
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/293037 | PRODUCTION OF OLIGODENDROCYTES FROM PLACENTA-DERIVED STEM CELLS | Nov 8, 2011 | Abandoned |
Array
(
[id] => 13137403
[patent_doc_number] => 10086012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Control and characterization of memory function
[patent_app_type] => utility
[patent_app_number] => 13/882705
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21735
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882705
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882705 | Control and characterization of memory function | Nov 3, 2011 | Issued |
Array
(
[id] => 8138587
[patent_doc_number] => 20120093842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 13/281560
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16284
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20120093842.pdf
[firstpage_image] =>[orig_patent_app_number] => 13281560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/281560 | CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH | Oct 25, 2011 | Abandoned |
Array
(
[id] => 8203214
[patent_doc_number] => 20120125348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY'
[patent_app_type] => utility
[patent_app_number] => 13/278591
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38911
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20120125348.pdf
[firstpage_image] =>[orig_patent_app_number] => 13278591
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/278591 | AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY | Oct 20, 2011 | Abandoned |
Array
(
[id] => 8906782
[patent_doc_number] => 20130174285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Model Animal for Studying Hair Growth Cycle'
[patent_app_type] => utility
[patent_app_number] => 13/819659
[patent_app_country] => US
[patent_app_date] => 2011-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11627
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819659
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/819659 | Model Animal for Studying Hair Growth Cycle | Sep 15, 2011 | Abandoned |
Array
(
[id] => 9149070
[patent_doc_number] => 20130303594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'HOT1 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/823431
[patent_app_country] => US
[patent_app_date] => 2011-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13393
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823431
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/823431 | HOT1 AND USES THEREOF | Sep 13, 2011 |